Price breadth, unusual activity and signed capital flow are separate observations
Price sequence unavailableA timestamped price sequence is unavailable.
RELATIVE CO-MOVEMENT
How the members are behaving together
Session-normalized
Observed intraday paths are not available for this group yet.
02 · WHY IT MATTERS
Why now and where the move could travel
Context and lead/lag links are evidence, not proof of causation or a forecast
WHY NOW
Verified recent context
0 items
No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.
WHY THIS GROUP EXISTS
Shared filing context
6/6 members covered
Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across FTNT, QLYS, RBRK, TENB.
product pipeline / R&D affecting expense
“Research and Development Three Months Ended June 30, Change (dollars in thousands) 2026 2025 ($) (%) Research and development $ 56,999 $ 59,236 $ (2,237) (4) % The decrease in research and development expense was primarily due to: • a $2.1 million increase in refundable research and development tax credits; and • a $0.9 million decrease in personnel costs, including a $1.3 million decrease in stock-based compensation and an unfavorable foreign currency impact of $3.1 million; partially offset by • a $0.6 million increase in third-party cloud infrastructure costs.”
“Interest Income, Interest Expense and Other Income (Expense), Net Three Months Ended June 30, Change (dollars in thousands) 2026 2025 ($) (%) Interest income $ 2,312 $ 4,080 $ (1,768) (43) % Interest expense (6,436) (7,139) (703) (10) % Other income (expense), net (1,308) 25 (1,333) (5,332) % The $1.8 million decrease in interest income was due to a decrease in short-term investments and reduced rates of return.”
“As a result of customer buying patterns and the efforts of our sales force and channel partners to meet or exceed quarterly quotas, we have historically received a substantial portion of each quarter’s sales orders and generated a substantial portion of each quarter’s billings and revenue during the last two weeks of the quarter.”
Most unusual activity in this snapshot; performance direction may differ.
04 · HAS THIS HAPPENED BEFORE
Identity history versus measured outcomes
Structural recurrence is not the same as a validated trading outcome
POINT-IN-TIME LIVE OUTCOMES
Live outcome ledger collecting
0/0 events completed
No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.
Low structural sample
Only 0 completed episodes across 0 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.
Structural support0 daysHow often the cohort identity was observed
Completed episodes0Separate periods of broad group activity
Active sessions0Completed session observations, not trades
Historical cohort observations are not available yet.